Ketamine Queen Awaits Sentencing for Role in Matthew Perry's Tragic Death
Jasveen Sangha, infamously dubbed the "Ketamine Queen," is scheduled to be sentenced on Wednesday after pleading guilty last year to selling a fatal dose of ketamine to beloved actor Matthew Perry. This case marks a significant development in the ongoing legal proceedings surrounding Perry's untimely death, with federal prosecutors vigorously arguing for a 15-year prison sentence. They emphasize Sangha's extensive involvement in the illicit drug trade and her apparent indifference to the devastating consequences of her actions.
Prosecutors Push for Severe Punishment in High-Profile Case
Federal authorities have submitted compelling court documents detailing why Sangha deserves a lengthy incarceration. They highlight the "far-reaching scope of defendant's illegality [and] her callous response to the deaths she helped cause," referencing not only Perry's death but also that of another individual, Cody McLaury. Prosecutors assert that Sangha's conduct demonstrates a "cold callousness and disregard for life," where she prioritized profits over human safety, leading to profound grief for the victims' families.
Matthew Perry, aged 54, passed away in October 2023, with medical officials determining that ketamine, a surgical anesthetic, was the primary cause. The iconic Friends star had a long history of battling addiction and had previously used ketamine under legal supervision to manage depression. However, when his physician declined to provide the quantities he desired, Perry turned to alternative sources, ultimately connecting with Sangha through intermediaries.
Comprehensive Legal Proceedings Involve Multiple Defendants
Sangha represents the fifth defendant to accept a plea deal in this complex case, which initially charged five individuals:
- Salvador Plasencia and Mark Chavez, two doctors who, while not supplying the lethal ketamine, were criticized by a judge for "continuing to feed his ketamine addiction."
- Kenneth Iwamasa, Perry's personal assistant, who administered the drug injection shortly before the actor's death.
- Erik Fleming, an acquaintance who facilitated the transaction as a middleman.
- Jasveen Sangha, who admitted to distributing approximately 50 vials of ketamine to Perry prior to his demise.
In her plea agreement, Sangha confessed to operating a drug distribution network from her North Hollywood residence since 2019, trafficking substances like ketamine and methamphetamine. Notably, she continued her dealings even after learning of the deaths linked to her products, a factor prosecutors heavily emphasized in their sentencing recommendations.
Defense Advocates for Leniency Based on Rehabilitation Efforts
Contrasting the prosecution's stance, Sangha's defense team, led by prominent attorneys Mark Geragos and Alexandra Kazarian, argues for a more lenient outcome. They point to her lack of prior criminal record, her admission of responsibility, and her active participation in recovery and rehabilitation programs during incarceration. The defense has submitted documents stating, "Ms Sangha's demonstrated rehabilitation, including two years of sustained sobriety, consistent engagement in recovery programming, and strong community support, reflects a meaningful commitment to change and a low risk of recidivism."
They propose that Sangha should be released with time served, highlighting her privileged background, education at a "well-respected university," and master's degree as factors that mitigate her actions, which they attribute to "greed, [glamour], and access." However, the presiding judge retains full discretion, meaning Sangha could potentially face up to 65 years in prison despite the plea agreement, underscoring the gravity of the charges.
This sentencing hearing not only concludes a chapter in the legal saga but also serves as a poignant reminder of the dangers of substance abuse and illicit drug markets. The outcome will be closely monitored by legal experts, fans of Matthew Perry, and advocates for stricter drug enforcement policies.
